Vise Technologies Inc. Invests $248,000 in Amedisys, Inc. (NASDAQ:AMED)

Vise Technologies Inc. purchased a new stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 2,727 shares of the health services provider's stock, valued at approximately $248,000.

Other large investors also recently modified their holdings of the company. Blue Trust Inc. boosted its stake in Amedisys by 55.1% during the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock valued at $34,000 after purchasing an additional 124 shares in the last quarter. Johnson Financial Group Inc. acquired a new stake in shares of Amedisys in the fourth quarter valued at $55,000. Vestcor Inc bought a new position in Amedisys during the fourth quarter valued at about $73,000. Venturi Wealth Management LLC boosted its stake in Amedisys by 397.4% during the fourth quarter. Venturi Wealth Management LLC now owns 975 shares of the health services provider's stock valued at $89,000 after buying an additional 779 shares in the last quarter. Finally, Covestor Ltd grew its holdings in Amedisys by 48.8% during the fourth quarter. Covestor Ltd now owns 1,037 shares of the health services provider's stock worth $94,000 after acquiring an additional 340 shares during the period. 94.36% of the stock is owned by institutional investors and hedge funds.

Amedisys Trading Up 0.4%

Shares of NASDAQ:AMED traded up $0.42 during midday trading on Monday, reaching $94.49. The company had a trading volume of 351,997 shares, compared to its average volume of 410,661. The company has a fifty day simple moving average of $93.52 and a two-hundred day simple moving average of $91.62. The firm has a market cap of $3.10 billion, a price-to-earnings ratio of 37.50, a price-to-earnings-growth ratio of 1.78 and a beta of 0.96. Amedisys, Inc. has a 1-year low of $82.15 and a 1-year high of $98.95. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The health services provider reported $1.25 EPS for the quarter, beating analysts' consensus estimates of $1.13 by $0.12. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The company had revenue of $594.78 million during the quarter, compared to analyst estimates of $597.43 million. During the same period in the prior year, the firm earned $1.03 earnings per share. The business's quarterly revenue was up 4.1% on a year-over-year basis. Research analysts predict that Amedisys, Inc. will post 4.4 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. Wall Street Zen downgraded shares of Amedisys from a "strong-buy" rating to a "buy" rating in a report on Saturday, May 24th. Stephens reiterated an "equal weight" rating and issued a $101.00 target price on shares of Amedisys in a report on Tuesday, March 4th. Finally, Royal Bank of Canada reissued an "outperform" rating and set a $100.00 target price on shares of Amedisys in a research note on Wednesday, April 16th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $100.75.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.